BOSTON– Global law firm Greenberg Traurig, LLP’s Life Sciences & Medical Technology Group has been named a finalist for three 2025 Life Sciences Patent Network (LSPN) Awards, recognizing the firm’s excellence and leadership in life sciences intellectual property (IP).
Greenberg Traurig is a finalist in the following categories:
– Life Sciences Patent Strategy Firm of the Year
– Life Sciences Prosecution Firm of the Year
– Patent Prosecutor of the Year – David Dykeman
“These nominations reflect the strength of Greenberg Traurig’s life sciences team, our strategic patent counsel, deep industry knowledge, and dedication to helping life sciences companies protect groundbreaking innovations,” said David J. Dykeman and Wayne H. Elowe, Co-Chairs of Greenberg Traurig’s Global Life Sciences & Medical Technology Group. “We are honored to be recognized among the leading firms shaping the future of life sciences IP.”
Organized by Life Sciences Intellectual Property Review, the LSPN Awards USA 2025 celebrate outstanding achievements in pharmaceutical and biotech patent protection. These awards honor organizations that are driving innovation, delivering exceptional results, and shaping the future of life sciences IP.
Winners will be announced at an awards ceremony on May 6, 2025 at The Colonnade Hotel in Boston.
Greenberg Traurig’s nationally ranked Life Sciences & Medical Technology Group advises a diverse client base, from start-ups and multinational corporations to leading research institutions. The group’s attorneys provide innovative legal counsel throughout the life sciences lifecycle—from discovery and development to commercialization and product marketing.
